Pitt Lands $14.3 Million for Research Linking Dementia and Cardiovascular Disease
A team from the University of Pittsburgh will launch a first-ever clinical trial to see if an immune regulator can reduce the deleterious aspects of aging in older but otherwise healthy adults.
Led by Anne Newman, Distinguished Professor of Epidemiology, clinical director of the Aging Institute and director of the Center for Aging and Public Health, this team will evaluate whether a monoclonal antibody that potently reduces inflammation can lead to improved cardiovascular and cognitive function. The Data Core for this trial will be housed at the Epidemiology Data Center and led by Dr. Marnie Bertolet, Associate Professor of Epidemiology.